Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricardo Alonso

Showing results (111-120 of 158) with videos related to

Pageof 16
Sort By:
Multiple Sclerosis Journal - Experimental, Translational and Clinical|July 2, 2021
Family planning in Argentinian women with multiple sclerosis: An important yet seldom approached issueRicardo Alonso, Liliana Patrucco, Berenice Silva, et al.
Multiple Sclerosis and Related Disorders|May 28, 2025
Latin American RAND/UCLA modified Delphi consensus recommendations for management and treatment of adult MOGAD patients in clinical practiceEdgar Carnero Contentti, Jorge Correale, Juan I Rojas, et al.
Multiple Sclerosis and Related Disorders|December 8, 2020
Usage trend of oral drugs for multiple sclerosis patients in ArgentinaRicardo Alonso, Orlando Garcea, María Barbara Eizaguirre, et al.
Multiple Sclerosis and Related Disorders|January 17, 2025
Recommendations on NMOSD treatment in Latin America: Utilizing consensus-based RAND/UCLA methodologyRicardo Alonso, Victor Rivera, Edgar German Carnero Contentti, et al.
Multiple Sclerosis and Related Disorders|January 15, 2022
Evaluation of the times of disability progression and related factors in patients with primary progressive multiple sclerosis from ArgentinaRicardo Alonso, Orlando Garcea, Juan Ignacio Rojas, et al.
Multiple Sclerosis and Related Disorders|June 8, 2019
Access and unmet needs to multiple sclerosis care in a cohort of Argentinean patientsEdgar Carnero Contentti, Juan Pablo Pettinicchi, Pablo A López, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2023
Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world settingEdgar Carnero Contentti, Pablo A Lopez, Verónica Tkachuk, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Rebound activity after fingolimod cessation: A case - control studyAndres Barboza, María Inés Gaitán, Ricardo Alonso, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 11, 2024
Cladribine use trend in Latin America: the changes in patient profile impact in the drug effectivenessBerenice A Silva, Alejandra Heriz, Jeremías Ayerbe, et al.
Clinical Neuropharmacology|July 15, 2024
Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in ArgentinaJuan Ignacio Rojas, Ricardo Alonso, Geraldine Luetic, et al.
Pageof 16

Showing results (111-120 of 158) with videos related to

Sort By:
Pageof 16
Multiple Sclerosis Journal - Experimental, Translational and Clinical|July 2, 2021
Family planning in Argentinian women with multiple sclerosis: An important yet seldom approached issueRicardo Alonso, Liliana Patrucco, Berenice Silva, et al.
Multiple Sclerosis and Related Disorders|May 28, 2025
Latin American RAND/UCLA modified Delphi consensus recommendations for management and treatment of adult MOGAD patients in clinical practiceEdgar Carnero Contentti, Jorge Correale, Juan I Rojas, et al.
Multiple Sclerosis and Related Disorders|December 8, 2020
Usage trend of oral drugs for multiple sclerosis patients in ArgentinaRicardo Alonso, Orlando Garcea, María Barbara Eizaguirre, et al.
Multiple Sclerosis and Related Disorders|January 17, 2025
Recommendations on NMOSD treatment in Latin America: Utilizing consensus-based RAND/UCLA methodologyRicardo Alonso, Victor Rivera, Edgar German Carnero Contentti, et al.
Multiple Sclerosis and Related Disorders|January 15, 2022
Evaluation of the times of disability progression and related factors in patients with primary progressive multiple sclerosis from ArgentinaRicardo Alonso, Orlando Garcea, Juan Ignacio Rojas, et al.
Multiple Sclerosis and Related Disorders|June 8, 2019
Access and unmet needs to multiple sclerosis care in a cohort of Argentinean patientsEdgar Carnero Contentti, Juan Pablo Pettinicchi, Pablo A López, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2023
Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world settingEdgar Carnero Contentti, Pablo A Lopez, Verónica Tkachuk, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Rebound activity after fingolimod cessation: A case - control studyAndres Barboza, María Inés Gaitán, Ricardo Alonso, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 11, 2024
Cladribine use trend in Latin America: the changes in patient profile impact in the drug effectivenessBerenice A Silva, Alejandra Heriz, Jeremías Ayerbe, et al.
Clinical Neuropharmacology|July 15, 2024
Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in ArgentinaJuan Ignacio Rojas, Ricardo Alonso, Geraldine Luetic, et al.
Pageof 16